Go Deep
GSK plc
GSK plc Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 18,793 | 15.8 | 4.23 | 1.06 | 2,357.67 |
| Oct 2026 | 18,818 | 15.7 | 4.21 | 1.06 | 2,343.89 |
| Oct 2026 | 18,773 | 15.8 | 4.24 | 1.06 | 2,360.95 |
| Oct 2026 | 18,775 | 15.8 | 4.24 | 1.06 | 2,363.23 |
| Oct 2026 | 18,622 | 16.2 | 4.35 | 1.06 | 2,420.48 |
GSK plc Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 8,409,000,000.0 | 7,629,000,000.0 | 8,618,000,000.0 | 8,547,000,000.0 |
| Net Profit | 435,000,000.0 | 1,737,000,000.0 | 636,000,000.0 | 2,013,000,000.0 |
| EPS | 0.1 | 0.4 | 0.2 | — |
GSK plc Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 32,667,000,000.0 | 31,376,000,000.0 | 30,328,000,000.0 | 29,324,000,000.0 | — |
| Net Profit | 5,716,000,000.0 | 2,575,000,000.0 | 4,928,000,000.0 | 14,956,000,000.0 | — |
| EPS | 1.4 | 0.6 | 1.2 | 3.7 | — |
GSK plc Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 61,118,000,000.0 | 59,463,000,000.0 | 59,005,000,000.0 | 60,146,000,000.0 | — |
| Total Liabilities | 45,162,000,000.0 | 46,377,000,000.0 | 46,210,000,000.0 | 50,050,000,000.0 | — |
| Total Equity | 16,377,000,000.0 | 13,671,000,000.0 | 13,347,000,000.0 | 10,598,000,000.0 | — |
Owes vs Owns
GSK plc owed £0.72 for every £1 it owned in Jun 2026, down from £0.83 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.72× | 0.74× | 0.78× | 0.78× | 0.83× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
GSK plc Assets & Liabilities Breakdown (GBP millions)
What it owns — Dec 2025
Cash & short-term investments 5.2%Receivables 9.7%Inventory 9.7%Fixed assets (tangible) 16.4%Intangible assets 38.9%Other assets 20.0%
How it's funded — Dec 2025
Short-term debt 4.7%Long-term debt 22.9%Payables 5.8%Other liabilities 40.5%Shareholders' equity 26.1%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 3,159.0 | 3,714.0 | 4,992.0 | 7,677.0 |
| Receivables | 5,913.0 | 5,563.0 | 5,905.0 | 5,452.0 |
| Inventory | 5,924.0 | 5,669.0 | 5,498.0 | 5,146.0 |
| Fixed assets (tangible) | 10,048.0 | 10,073.0 | 9,957.0 | 9,620.0 |
| Intangible assets | 23,766.0 | 22,497.0 | 21,579.0 | 21,364.0 |
| Long-term investments | 89.0 | 96.0 | 55.0 | 74.0 |
| Other assets | 12,219.0 | 11,851.0 | 11,019.0 | 10,813.0 |
| Liabilities & equity | ||||
| Short-term debt | 2,875.0 | 2,181.0 | 2,657.0 | 3,785.0 |
| Long-term debt | 14,015.0 | 13,703.0 | 14,154.0 | 16,194.0 |
| Payables | 3,535.0 | 3,462.0 | 3,717.0 | 3,866.0 |
| Other liabilities | 24,737.0 | 27,031.0 | 25,682.0 | 26,205.0 |
| Shareholders' equity | 15,956.0 | 13,086.0 | 12,795.0 | 10,096.0 |
| Net tangible assets | -7,389.0 | -8,826.0 | -8,232.0 | -10,766.0 |
GSK plc Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 7,741,000,000.0 | 6,554,000,000.0 | 6,768,000,000.0 | 7,403,000,000.0 | — |
| Investing Activities | -4,233,000,000.0 | -1,229,000,000.0 | -1,595,000,000.0 | -8,772,000,000.0 | — |
| Financing Activities | -3,685,000,000.0 | -4,726,000,000.0 | -5,641,000,000.0 | 823,000,000.0 | — |